Burning Rock Biotech is a Chinese company that develops and offers tests for cancer therapy selection and prognosis prediction. The tests are next-generation sequencing-based and can be used for various types of cancer using tissue and liquid biopsy samples. The company has collaborations with numerous pharmaceutical companies, including AstraZeneca, Bayer, and Johnson & Johnson, and has agreements to in-license tumor testing and risk stratification tests.